With game changer therapies and unprecedented clinical successs for patients, Immunotherapy has becomes an essential pillar for cancer treatment. During this webinar, Michael Esquerre, our VP, In Vitro Biology, discusses how the team at Evotec are pusing Immuno-Oncology drug discovery, playing with multi-therapeutic modalities. Stream it on demand now!